Ambrose Kristen sold VRTX
February 11, 2026 · Form 4 insider transaction
Ambrose Kristen sold 1,376 shares of Vertex Pharmaceuticals Incorporated at $460.43 per share, a transaction worth $633.6K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
1,376
Price
$460.43
Total value
$633.6K
InsiderAmbrose Kristen
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 11, 2026
Filing dateFebruary 12, 2026
Shares owned after10,127
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Transaction made pursuant to Ms. Ambrose's company approved trading plan under Rule 10b5-1, which was entered into on 08/08/2025.